Arrow Investment Advisors LLC Sells 15,858 Shares of Global Medical REIT Inc. $GMRE

Arrow Investment Advisors LLC lowered its position in shares of Global Medical REIT Inc. (NYSE:GMRE) by 71.3% during the 3rd quarter, Holdings Channel.com reports. The firm owned 6,374 shares of the company’s stock after selling 15,858 shares during the period. Arrow Investment Advisors LLC’s holdings in Global Medical REIT were worth $215,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. New York State Teachers Retirement System bought a new stake in shares of Global Medical REIT during the 3rd quarter valued at $39,000. State of Alaska Department of Revenue increased its stake in Global Medical REIT by 5.1% in the 2nd quarter. State of Alaska Department of Revenue now owns 30,876 shares of the company’s stock worth $213,000 after buying an additional 1,510 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its stake in Global Medical REIT by 2.9% in the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 88,000 shares of the company’s stock worth $610,000 after buying an additional 2,500 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in Global Medical REIT by 70.3% during the second quarter. Tower Research Capital LLC TRC now owns 7,379 shares of the company’s stock valued at $51,000 after acquiring an additional 3,046 shares during the period. Finally, AQR Capital Management LLC lifted its position in shares of Global Medical REIT by 9.5% in the first quarter. AQR Capital Management LLC now owns 58,538 shares of the company’s stock valued at $512,000 after acquiring an additional 5,062 shares in the last quarter. 57.52% of the stock is currently owned by institutional investors.

Global Medical REIT Price Performance

GMRE stock opened at $35.96 on Wednesday. Global Medical REIT Inc. has a 52 week low of $29.05 and a 52 week high of $45.75. The firm has a market capitalization of $482.22 million, a P/E ratio of -143.84 and a beta of 1.18. The company has a fifty day simple moving average of $33.88 and a two-hundred day simple moving average of $34.18. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 1.65.

Global Medical REIT (NYSE:GMRE) last announced its earnings results on Tuesday, November 4th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.07. Global Medical REIT had a net margin of 0.79% and a return on equity of 0.25%. The firm had revenue of $37.23 million for the quarter, compared to analysts’ expectations of $38.15 million. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. Analysts anticipate that Global Medical REIT Inc. will post 0.81 earnings per share for the current fiscal year.

Global Medical REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 19th were paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 8.3%. The ex-dividend date of this dividend was Friday, December 19th. Global Medical REIT’s dividend payout ratio (DPR) is presently -1,200.00%.

Insider Activity at Global Medical REIT

In related news, CEO Mark Okey Decker, Jr. bought 10,000 shares of the business’s stock in a transaction dated Friday, November 14th. The shares were purchased at an average price of $32.58 per share, with a total value of $325,800.00. Following the transaction, the chief executive officer owned 44,774 shares in the company, valued at $1,458,736.92. This trade represents a 28.76% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 8.50% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Robert W. Baird cut their target price on Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. JMP Securities set a $40.00 price objective on shares of Global Medical REIT and gave the company a “market outperform” rating in a report on Monday, October 13th. Zacks Research upgraded shares of Global Medical REIT from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, September 24th. Citigroup upgraded shares of Global Medical REIT to an “outperform” rating in a research report on Monday, October 13th. Finally, Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Global Medical REIT presently has a consensus rating of “Moderate Buy” and an average price target of $41.50.

Global Medical REIT Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.